USANA Health Sciences (USNA) versus Nautilus Group, Inc. (The) (NLS) Financial Review
USANA Health Sciences (NYSE: USNA) and Nautilus Group, Inc. (The) (NYSE:NLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.
Institutional and Insider Ownership
44.6% of USANA Health Sciences shares are held by institutional investors. Comparatively, 93.8% of Nautilus Group, Inc. (The) shares are held by institutional investors. 53.2% of USANA Health Sciences shares are held by company insiders. Comparatively, 3.7% of Nautilus Group, Inc. (The) shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares USANA Health Sciences and Nautilus Group, Inc. (The)’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|USANA Health Sciences||8.79%||26.54%||19.22%|
|Nautilus Group, Inc. (The)||7.28%||18.54%||9.76%|
This is a summary of recent ratings and recommmendations for USANA Health Sciences and Nautilus Group, Inc. (The), as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|USANA Health Sciences||0||0||1||0||3.00|
|Nautilus Group, Inc. (The)||0||3||4||0||2.57|
USANA Health Sciences presently has a consensus target price of $80.00, suggesting a potential upside of 22.04%. Nautilus Group, Inc. (The) has a consensus target price of $19.00, suggesting a potential upside of 53.23%. Given Nautilus Group, Inc. (The)’s higher possible upside, analysts plainly believe Nautilus Group, Inc. (The) is more favorable than USANA Health Sciences.
Earnings and Valuation
This table compares USANA Health Sciences and Nautilus Group, Inc. (The)’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|USANA Health Sciences||$1.01 billion||1.59||$100.04 million||$3.63||18.06|
|Nautilus Group, Inc. (The)||$406.04 million||0.94||$34.17 million||$0.95||13.05|
USANA Health Sciences has higher revenue and earnings than Nautilus Group, Inc. (The). Nautilus Group, Inc. (The) is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
USANA Health Sciences has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Nautilus Group, Inc. (The) has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500.
USANA Health Sciences beats Nautilus Group, Inc. (The) on 10 of the 14 factors compared between the two stocks.
About USANA Health Sciences
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
About Nautilus Group, Inc. (The)
Nautilus, Inc. is a consumer fitness products company. The Company operates through two segments: Direct and Retail. Its principal business activities include designing, developing, sourcing and marketing of cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada, but also in international markets outside North America. The Direct business offers products directly to consumers through television advertising, catalogs and the Internet. In its Direct business, the Company markets and sells its products, principally Bowflex cardio and strength products, directly to consumers. The Retail business offers its products through a network of independent retail companies and specialty retailers with stores and Websites located in the United States and internationally. In its Retail business, the Company markets and sells a line of consumer fitness equipment under the Nautilus, Octane Fitness, Schwinn, Universal and Bowflex brands.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.